Si-Mei Shi

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)

W. Wang, W. Fang, Fenghua Wang, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer

Fenghua Wang, Yu-hong Li, R. Xu, 2019, BMC Cancer.

FcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer

Fenghua Wang, Yu-hong Li, R. Xu, 2017, OncoTargets and therapy.

Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer

Fenghua Wang, P. Ding, Yu-hong Li, 2019, Cancer medicine.

Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER‐based study

Fenghua Wang, Yu-hong Li, D. Xie, 2018, Cancer medicine.

Comparison of HER2 and Lauren Classification between Biopsy and Surgical Resection Samples, Primary and Metastatic Samples of Gastric Cancer

J. Yun, Fenghua Wang, Jing Wang, 2017, Journal of Cancer.

Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer

Fenghua Wang, Yu-hong Li, R. Xu, 2019, BMC Cancer.